Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety
Standard doses of lithium and aripiprazole were associated with the lowest risk of relapse, and standard dose of lithium with the lowest risk of non-psychiatric hospitalization. Quetiapine was not associated with decreased risk of relapse at any dose.
Authors
- Aleksi Hamina (ORCID: https://orcid.org/0000-0003-2417-4059)
- Antti J. Tanskanen (ORCID: https://orcid.org/0000-0002-3795-3126)
- Heidi T. Taipale (ORCID: https://orcid.org/0000-0002-3281-934X)
- Jari Tiihonen (ORCID: https://orcid.org/0000-0002-0400-6798)
- Jonne Lintunen (ORCID: https://orcid.org/0000-0001-5627-2388)
- Tapio Paljärvi (ORCID: https://orcid.org/0000-0002-5324-9825)
- Markku Lähteenvuo (ORCID: https://orcid.org/0000-0002-7244-145X)
Institutions
- University of Helsinki (FI)
- University of Eastern Finland (FI)
- University of Oslo (NO)
- Niuvanniemi Hospital (FI)
- Karolinska Institutet (SE)
Publication Details
- Journal
- Acta Psychiatrica Scandinavica
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1111/acps.13762
- Citations
- 6
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.31
Funders
- Sosiaali- ja Terveysministeriö